During a Senate Finance hearing, Robert F. Kennedy Jr. faced scrutiny for maintaining financial ties to litigation against Merck, the manufacturer of the Gardasil vaccine. Critics, including Senator Elizabeth Warren, accused him of potential profiteering from vaccine skepticism. Despite planned changes to his referral arrangements with the Wisner Baum law firm, Kennedy intends to collect fees from ongoing cases, raising questions about conflicts of interest as he seeks a role in public health regulation.
Mr. Kennedy's decision to maintain a financial stake in litigation against a vaccine maker raises ethical concerns and accusations of profiteering amid vaccine skepticism.
Senator Warren criticized Mr. Kennedy's financial dealings, suggesting that it contradicts his claims regarding the motivations of drug companies and federal officials.
Collection
[
|
...
]